semaglutide cancer Weight loss drug may boost immune cells that fight cancer: Study In a major new JAMA
Description
Semaglutide is a GLP-1 receptor agonist found in three FDA-approved medications by Novo Nordisk: Ozempic : an injectable used to lower blood sugar and reduce cardiovascular risk in adults with type 2 diabetes
A primary advantage of the pill is that it does not require refrigeration, making it more convenient for travel. While most studies indicate that oral forms may be slightly less effective than injections, they remain very effective
Next, remove the box of Ozempic from your refrigerator
The Indian Journal of Medical Research
:max_bytes(150000):strip_icc()/VWHealth-Could-GLP-1Drugs-Reduce-Obesity-Related-Cancers-in-the-Future-3-7d602ab39c0448ddb00cd91b06be2a84.jpg)
FAQs Is tiredness normal on GLP-1
